Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian+17 more
wiley +1 more source
Association of metformin administration after septic shock with short-term and long-term survival in septic shock patients with diabetes. [PDF]
Jin BY+6 more
europepmc +1 more source
Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase [PDF]
Wiebke Arlt+2 more
openalex +1 more source
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian, A. Soukas
semanticscholar +1 more source
Quinazoline represents an important class of heterocycles with diverse medicinal and pharmacological significance. This review systematically examines scholarly efforts toward understanding different synthetic pathways emphasizing the role of metal and non‐metal catalysts including some miscellaneous reagents employed in the synthesis of quinazoline ...
Neha Manhas+4 more
wiley +1 more source
Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
Inhibition of leptin secretion by insulin and metformin in cultured rat adipose tissue
Gail J. Mick+3 more
openalex +1 more source
The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study [PDF]
Timothy M. E. Davis+4 more
openalex +1 more source
Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk+5 more
wiley +1 more source